3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and a focus for angry and heartbroken reproach.
In some measure, that’s unavoidable. The agency decides what lifesaving and life-transforming drugs are to be supplied - and denied - to New Zealanders.
People suffer and die when it makes bad calls. Also when it makes good ones. Such is the cruelty of prioritising under a fixed budget.